Zhen Gu
Impact in
- Pharmaceutical Science top 0.01%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Biomaterials top 0.01%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 64
- Advanced biosensing and bioanalysis techniques 38
- Lipid Membrane Structure and Behavior 36
-
- Nanoplatforms for cancer theranostics 83
- Co-authors
- Quanyin Hu (61 shared papers)Wujin Sun (60 shared papers)Chao Wang (40 shared papers)Jicheng Yu (95 shared papers)Jinqiang Wang (86 shared papers)Yanqi Ye (32 shared papers)Yue Lü (18 shared papers)Ran Mo (18 shared papers)
- Journals
- Advanced Materials (41 papers)ACS Nano (24 papers)Science Advances (16 papers)Nature Communications (13 papers)Nano Letters (11 papers)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Zhen Gu
386 papers receiving 41.5k citations
Zhen Gu's Hit Papers
Peers
Comparison fields: 5 of 180
- Pharmaceutical Science 7.2k
- Biomaterials 10.7k
- Biomedical Engineering 18.3k
- Molecular Medicine 1.6k
- Immunology 5.8k
Countries citing papers authored by Zhen Gu
This map shows the geographic impact of Zhen Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Gu more than expected).
Fields of papers citing papers by Zhen Gu
This network shows the impact of papers produced by Zhen Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Gu. The network helps show where Zhen Gu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen Gu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 402 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bioresponsive materials Hit paper breakdown → | 2016 | 1288 |
| 2 | In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment Hit paper breakdown → | 2018 | 897 |
| 3 | Enzyme-activatable polymer–drug conjugate augments tumour penetration and treatment efficacy Hit paper breakdown → | 2019 | 742 |
| 4 | Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery Hit paper breakdown → | 2015 | 738 |
| 5 | Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody Hit paper breakdown → | 2016 | 707 |
| 6 | ATP-triggered anticancer drug delivery Hit paper breakdown → | 2014 | 637 |
| 7 | Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species Hit paper breakdown → | 2017 | 611 |
| 8 | Anticancer Platelet‐Mimicking Nanovehicles Hit paper breakdown → | 2015 | 573 |
| 9 | Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing Hit paper breakdown → | 2015 | 569 |
| 10 | Enzyme-responsive nanomaterials for controlled drug delivery Hit paper breakdown → | 2014 | 550 |
| 11 | Recent advances of cocktail chemotherapy by combination drug delivery systems Hit paper breakdown → | 2015 | 546 |
| 12 | In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy Hit paper breakdown → | 2018 | 528 |
| 13 | Transformable liquid-metal nanomedicine Hit paper breakdown → | 2015 | 526 |
| 14 | Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs Hit paper breakdown → | 2020 | 514 |
| 15 | Tailoring nanocarriers for intracellular protein delivery Hit paper breakdown → | 2011 | 502 |
| 16 | In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy Hit paper breakdown → | 2017 | 477 |
| 17 | Light‐Activated Hypoxia‐Responsive Nanocarriers for Enhanced Anticancer Therapy Hit paper breakdown → | 2016 | 438 |
| 18 | Advances in liquid metals for biomedical applications Hit paper breakdown → | 2018 | 432 |
| 19 | Injectable Nano-Network for Glucose-Mediated Insulin Delivery Hit paper breakdown → | 2013 | 422 |
| 20 | Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells Hit paper breakdown → | 2019 | 405 |
About Zhen Gu
Zhen Gu is a scholar working on Molecular Biology, Biomedical Engineering, Biomaterials, Pharmaceutical Science and Immunology, having authored 402 papers that have together received 41.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (83 papers), Nanoparticle-Based Drug Delivery (74 papers), RNA Interference and Gene Delivery (64 papers), Advancements in Transdermal Drug Delivery (63 papers), Advanced Drug Delivery Systems (42 papers), Immunotherapy and Immune Responses (40 papers), Advanced biosensing and bioanalysis techniques (38 papers) and Lipid Membrane Structure and Behavior (36 papers). The work is most often cited by research in Pharmaceutical Science (7.2k citations), Biomaterials (10.7k citations), Biomedical Engineering (18.3k citations), Molecular Medicine (1.6k citations) and Immunology (5.8k citations). Zhen Gu has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Quanyin Hu, Wujin Sun, Chao Wang, Jicheng Yu, Jinqiang Wang, Yanqi Ye, Yue Lü, Ran Mo, Guojun Chen and Tianyue Jiang. Their work appears in journals such as Advanced Materials, ACS Nano, Science Advances, Nature Communications and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.